Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-19

Clinical Trial Update: The Effect of Vitamin D Supplementation on Calcium Excretion in Thalassemia: a Dose Response Study [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update examining how vitamin D supplementation affects calcium excretion in patients with thalassemia major, using a dose-response desi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cholecalciferol (Vitamin D3)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Thalassemia Major | Phase 4 | Status: UNKNOWN